1. Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancers. (October 2020) Authors: Yang, Haiyan; Zhou, Zhen; Lin, Li; Yang, Mingxia; Li, Chong; Li, Ziming; Yu, Xinmin; Lizaso, Analyn; Han-Zhang, Han; Li, Bing; Xiang, Jianxing; Mao, Xinru; Xu, Qinqin; Zhang, Yongchang; Yang, Nong Journal: Lung cancer Issue: Volume 148(2020) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of genetic profiles among primary lung tumor, metastatic lymph nodes and circulating tumor DNA in treatment-naïve advanced non-squamous non-small cell lung cancer patients. (July 2018) Authors: Xie, Fangfang; Zhang, Yujun; Mao, Xiaowei; Zheng, Xiaoxuan; Han-Zhang, Han; Ye, Junyi; Zhao, Ruiying; Zhang, Xueyan; Sun, Jiayuan Journal: Lung cancer Issue: Volume 121(2018) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients. Issue 4 (October 2020) Authors: Xiong, Liwen; Lou, Yuqing; Bai, Hao; Li, Rong; Xia, Jinjing; Fang, Wentao; Zhang, Jie; Han-Zhang, Han; Lizaso, Analyn; Li, Bing; Gu, Aiqin; Han, Baohui Journal: Journal of international medical research Issue: Volume 48:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Heterogeneity of genomic profile in patients with HER2-positive breast cancer. Issue 3 (March 2020) Authors: Chen, Bo; Zhang, Guochun; Wei, Guangnan; Wang, Yulei; Guo, Liping; Lin, Jiali; Li, Kai; Mok, Hsiaopei; Cao, Li; Ren, Chongyang; Wen, Lingzhu; Jia, Minghan; Li, Cheukfai; Hou, Ting; Han-Zhang, Han; Liu, Jing; Balch, Charles M; Liao, Ning Journal: Endocrine-related cancer Issue: Volume 27:Issue 3(2020) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Heterogeneity of genomic profile in patients with HER2-positive breast cancer. Issue 3 (March 2020) Authors: Chen, Bo; Zhang, Guochun; Wei, Guangnan; Wang, Yulei; Guo, Liping; Lin, Jiali; Li, Kai; Mok, Hsiaopei; Cao, Li; Ren, Chongyang; Wen, Lingzhu; Jia, Minghan; Li, Cheukfai; Hou, Ting; Han-Zhang, Han; Liu, Jing; Balch, Charles M; Liao, Ning Journal: Endocrine-related cancer Issue: Volume 27:Issue 3(2020) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose phase 1b study. (September 2021) Authors: Ji, Linong; Jiang, Hongwei; An, Pei; Deng, Huan; Liu, Meng; Li, Li; Feng, Liqi; Song, Baili; Han-Zhang, Han; Ma, Qingyang; Qian, Lei Journal: EClinicalMedicine Issue: Volume 39(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mutational landscape and clonal diversity of pulmonary adenoid cystic carcinoma. Issue 10 (3rd October 2018) Authors: Li, Min; Zhao, Bing-Rong; Liu, Shi-Qing; An, Jian; Deng, Peng-Bo; Han-Zhang, Han; Ye, Jun-Yi; Mao, Xin-Ru; Chuai, Shao-Kun; Hu, Cheng-Ping Journal: Cancer biology & therapy Issue: Volume 19:Issue 10(2018) Page Start: 898 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer. Issue 2 (27th August 2020) Authors: Mo, Shaobo; Ma, Xiaoji; Li, Yaqi; Zhang, Long; Hou, Ting; Han-Zhang, Han; Qian, Juanjuan; Cai, Sanjun; Huang, Dan; Peng, Junjie Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer. Issue 2 (27th August 2020) Authors: Mo, Shaobo; Ma, Xiaoji; Li, Yaqi; Zhang, Long; Hou, Ting; Han-Zhang, Han; Qian, Juanjuan; Cai, Sanjun; Huang, Dan; Peng, Junjie Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer. Issue 2 (27th August 2020) Authors: Mo, Shaobo; Ma, Xiaoji; Li, Yaqi; Zhang, Long; Hou, Ting; Han-Zhang, Han; Qian, Juanjuan; Cai, Sanjun; Huang, Dan; Peng, Junjie Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗